Showing 1 - 10 of 36,222
This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological...
Persistent link: https://www.econbiz.de/10004961229
relatedness ; technological relatedness ; coherence …
Persistent link: https://www.econbiz.de/10003833242
This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a...
Persistent link: https://www.econbiz.de/10010267114
coherence vs. market coherence and of accumulated knowledge on the productivity of firms differs. Productivity increases with … the number of patents and decreases with the patent diversity and project portfolio coherence. When considering only the …
Persistent link: https://www.econbiz.de/10010270030
coherence vs. market coherence and of accumulated knowledge on the productivity of firms differs. Productivity increases with … the number of patents and decreases with the patent diversity and project portfolio coherence. When considering only the … ; diversity ; coherence ; knowledge …
Persistent link: https://www.econbiz.de/10003989032
This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a...
Persistent link: https://www.econbiz.de/10003883005
Pharmaceutical firms spend billions of dollars to develop the next breakthrough drug and to maintain their market shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has been found to result in better performance outcomes....
Persistent link: https://www.econbiz.de/10012502063
This paper empirically investigates the determinants of R&D diversification strategies in the drug industry. It enriches the existing literature by proposing to look at diversification factors, which reflect market and technological proximity of an R&D project towards other projects within a...
Persistent link: https://www.econbiz.de/10008481990
What is the interaction between competition, R&D investments, and the financing choices of R&D-intensive firms? Motivated by existing theories, we hypothesize that as competition increases, R&D-intensive firms will: (1) increase R&D investment relative to assets-in-place that support existing...
Persistent link: https://www.econbiz.de/10012937531
The interaction between product market competition, R&D investment, and the financing choices of R&D-intensive firms on the development of innovative products is only partially understood. To motivate empirical hypotheses about this interaction, we develop a model which predicts that as...
Persistent link: https://www.econbiz.de/10013249274